Business Context and Reporting Period
Company: cbdMD, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: April 7, 2022
Reporting Period: Event date April 7, 2022; Signed April 12, 2022.
Context: The Company is an emerging growth company incorporated in North Carolina. This filing reports the entry into a material definitive agreement as part of ongoing cost optimization initiatives.
Key Financial Metrics
This filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, or total debt levels. The only specific financial value disclosed relates to the transaction described below:
- Equipment Sale Value: Approximately $1.8 million (for accounting purposes).
- Transaction Structure: The sale price consists of products to be provided under a new manufacturing and supply agreement plus a $1.4 million equity investment by the Company into Steady State, LLC.
Material Changes
On April 7, 2022, cbdMD, Inc. executed two simultaneous agreements with a subsidiary of Steady State, LLC (an existing qualified supplier):
- Equipment Purchase Agreement: The Company agreed to sell substantially all of its manufacturing equipment to Steady State.
- Manufacturing and Supply Agreement: Steady State will manufacture certain products for the Company.
This represents a strategic shift from owning manufacturing assets to outsourcing production while maintaining a financial stake in the supplier.
Guidance, Outlook, and Risks
Management Commentary: The transaction is explicitly described as part of "ongoing initiatives to cost optimization."
Outlook: The Company will continue to receive products from Steady State under the new supply agreement.
Risks and Contingencies: The filing notes that the description of the agreement terms is qualified in its entirety by reference to the full text of the agreement, which was expected to be filed in the Quarterly Report on Form 10-Q for the period ended March 31, 2022, or via an amendment to this 8-K.
Investor Verification Checklist
- Verify the full text of the equipment purchase and manufacturing agreements in the subsequent Form 10-Q or 8-K amendment.
- Confirm the valuation methodology for the $1.8 million equipment sale and the $1.4 million equity investment.
- Assess the impact of outsourcing manufacturing on future cost structures and gross margins.
- Review the terms of the equity investment in Steady State to understand potential dilution or return on investment.